Jana Winterová
About
In The Last Decade
Jana Winterová
13 papers receiving 335 citations
Peers
Comparison fields: 5 of 54
- Infectious Diseases 294
- Epidemiology 258
- Cell Biology 57
- Pulmonary and Respiratory Medicine 36
- Pharmacology 24
Countries citing papers authored by Jana Winterová
This map shows the geographic impact of Jana Winterová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Winterová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Winterová more than expected).
Fields of papers citing papers by Jana Winterová
This network shows the impact of papers produced by Jana Winterová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Winterová. The network helps show where Jana Winterová may publish in the future.
Co-authorship network of co-authors of Jana Winterová
This figure shows the co-authorship network connecting the top 25 collaborators of Jana Winterová. A scholar is included among the top collaborators of Jana Winterová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Winterová. Jana Winterová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 49 | |
| 3 | 43 | |
| 4 | 2 | |
| 5 | 95 | |
| 6 | Difficulties in using 1,3-beta--glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies - high frequency of false-positive results and their analysis. | 22 |
| 7 | 42 | |
| 8 | [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results]. | 6 |
| 9 | [The use of galactomannan detection in diagnosing invasive aspergillosis in hemato-oncological patients]. | 2 |
| 10 | [Invasive aspergillosis in hematooncological patients: advantages and disadvantages of various diagnostic methods, treatment options and financial costs of therapy]. | 2 |
| 11 | 37 | |
| 12 | [Contribution of galactomannan antigen detection to early diagnosis of invasive aspergillosis]. | 2 |
| 13 | 22 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.